Literature DB >> 9017508

Localization of apolipoprotein A-I epitopes involved in the activation of lecithin:cholesterol acyltransferase.

P Uboldi1, M Spoladore, S Fantappiè, S Marcovina, A L Catapano.   

Abstract

Eight murine monoclonal antibodies (Mab) to apolipoprotein A-I were characterized for their epitopes and for their ability to interfere with lecithin:cholesterol acyltransferase (LCAT) activation mediated by apo apoA-I using a synthetic substrate. Using overlapping synthetic peptides we have identified six continuous epitopes that span amino acids 1-10 (Mab A-I-19), 96-101 (Mab A-I-15), 133-141 (Mab A-I-5), 140-145 (Mab A-I-9), 144-148 (Mab A-I-8), and 167-174 (Mab A-I-57). Furthermore, antibodies A-I-11 and A-I-16 recognized discontinuous epitopes, namely amino acids 124-128 and 144-148. When antibodies were tested for their ability to inhibit LCAT activation, an inhibitory effect was observed with those whose epitopes covered the area of apoA-I encompassing amino acids 96-174. From these data we conclude that several areas of apoA-I spanning the middle region of the apolipoprotein act in concert to stimulate LCAT activity, possibly by cooperative interaction with the enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9017508

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  3 in total

1.  Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I.

Authors:  Martin K Jones; Andrea Catte; Ling Li; Jere P Segrest
Journal:  Biochemistry       Date:  2009-12-01       Impact factor: 3.162

2.  Conservation of apolipoprotein A-I's central domain structural elements upon lipid association on different high-density lipoprotein subclasses.

Authors:  Michael N Oda; Madhu S Budamagunta; Ethan G Geier; Sajiv H Chandradas; Baohai Shao; Jay W Heinecke; John C Voss; Giorgio Cavigiolio
Journal:  Biochemistry       Date:  2013-09-17       Impact factor: 3.162

3.  Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.

Authors:  Linda S May-Zhang; Valery Yermalitsky; John T Melchior; Jamie Morris; Keri A Tallman; Mark S Borja; Tiffany Pleasent; Venkataraman Amarnath; Wenliang Song; Patricia G Yancey; W Sean Davidson; MacRae F Linton; Sean S Davies
Journal:  J Biol Chem       Date:  2019-10-30       Impact factor: 5.486

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.